SARS-CoV-2 is like a Trojan horse: How virus breaks into placental fortress
- Targeting Sugar Molecules in Sugar-Immune Therapy
- Monkeypox Initial Infection Provides Protection Against Secondary Infection
- What is Genetic Toxicity of Base Editing and Prime Editing?
- What is the Scientific Foundation of mRNA Technology?
- This amino acid can significantly alleviate post-COVID-19 sequelae!
- What are Challenges in CAR-T Cell Therapy for Cancer treatment?
SARS-CoV-2 is like a Trojan horse: Researchers figure out how virus breaks into placental fortress
- Cardiovascular Diseases Linked to COVID-19 Infections
- FDA’s First Potential TIL Therapy Review Delayed: How to Understand FDA’s “Resource Constraints”?
- A Chinese Doctor Accused of Accepting Bribes Totaling US$166 Million
- Nuclear contaminated water: Japanese government paid bribes and corrected the IAEA report
- Top 20 Companies of Instruments and Medical Equipment In The World
- The first DMD gene therapy SRP-9001 may cost 4 million US dollars
- How long can the patient live after heart stent surgery?
SARS-CoV-2 is like a Trojan horse: Researchers figure out how virus breaks into placental fortress.
In a landmark study published on July 1 in Nature Cell Biology, researchers from Monash University and the University of Adelaide Australian researchers led by Professor Jose Polo of Adelaide and Professor Kanta Subbarao of the University of Melbourne’s Peter Doherty Institute for Infection and Immunity have revealed how COVID-19 infects humans placenta.
Studies have shown that COVID-19 infection during pregnancy may lead to adverse outcomes, but little is known about the mechanisms underlying the effects of SARS-CoV-2 infection during pregnancy.
Placental cells (syncytia, green) infected with the SARS-CoV-2 virus (COVID-19, red); blue areas are nuclei, labeled multinucleated syncytia. Source: Monash University
Using a state-of-the-art method developed by Professor Polo and colleagues, the Australian research team ‘reprogrammed’ human skin cells into trophoblast stem cells (cells that help a developing embryo attach to the wall of the uterus, forming part of the placenta).
They found that the protein ACE2, which acts as a gateway for SARS-CoV-2 to enter organs such as the lungs, is present in specific placental cells, such as syncytiotrophoblast cells (ST cells).
Importantly, ST cells were susceptible to the virus—a major finding because these placental cells produce a hormone (hCG) critical for maintaining pregnancy.
Dr Joseph Chen, a stem cell biologist at Monash University and co-first author of the report, said the finding explained several clinical reports showing that COVID-19 caused the placenta to be penetrated by the virus.
“We observed that SARS-CoV-2 infection resulted in a significant reduction in ST cell survival and differentiation, which in turn resulted in reduced hCG production. This suggests how COVID-19 affects pregnancy, although further research is needed,” he said.
“Our team also found that anti-ACE2 antibodies and antiviral drugs were effective in preventing SARS-CoV -2 infection, and restore normal differentiation and function of ST.”
Professor Subbarao said the research is a major advance in the wider understanding of viral infections in pregnancy: “Our study provides valuable insights into the link between SARS-CoV-2 infection and placental pathology. This change This is a game changer because we now have the ability to explore how the early placenta is affected by other viruses.”
Professor Polo emphasized the importance of this study in establishing a platform for the study of early placental cell types. “Not only does this research help us understand what happens when the placenta is infected with the COVID-19 virus during pregnancy, it also means we have established a broader, scalable and operational platform to study early placental cell types,” he said. “
SARS-CoV-2 is like a Trojan horse: Researchers figure out how virus breaks into placental fortress
(source:internet, reference only)
Disclaimer of medicaltrend.org
